IFRX
InflaRx N.V.NASDAQHealthcare$0.91+1.04%ClosedMarket Cap: $66.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.28
P/S
2031.97
EV/EBITDA
-0.87
DCF Value
$0.20
FCF Yield
-59.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-26108.5%
Operating Margin
-173594.0%
Net Margin
-155584.2%
ROE
-81.8%
ROA
-79.5%
ROIC
-115.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $-35.1K | 14276.8% | $-13.5M | $-8.8M | $-0.14 | — |
| FY 2025 | $28.2K | -26108.5% | $-48.9M | $-43.8M | $-0.66 | — |
| Q3 2025 | $23.8K | 98.6% | $-9.5M | $-12.3M | $-0.18 | — |
| Q2 2025 | $39.4K | -5985.4% | $-12.9M | $-14.4M | $-0.21 | — |
| Q1 2025 | $0.00 | -Infinity% | $-13.0M | $-8.3M | $-0.13 | — |
| Q4 2024 | $-423.00 | 666984.2% | $-9.8M | $-5.1M | $-0.09 | — |
| FY 2024 | $165.8K | -1900.8% | $-53.0M | $-46.1M | $-0.78 | — |
| Q3 2024 | $123.8K | 158.6% | $-15.4M | $-17.4M | $-0.30 | — |
| Q2 2024 | $6.4K | -5376.7% | $-15.4M | $-13.8M | $-0.24 | — |
| Q1 2024 | $36.0K | -511.9% | $-12.5M | $-9.7M | $-0.16 | — |
| Q4 2023 | $2.2K | -14994.4% | $-12.8M | $-15.6M | $-0.26 | — |
| FY 2023 | $63.1K | -743.7% | $-44.9M | $-42.7M | $-0.78 | — |